Mobilization With Movement in Rotator Cuff Tendinopathy
Effects of Mobilization With Movement on Tendon Morphology, Pain, and Function in Patients With Rotator Cuff Tendinopathy: A Randomized Controlled Trial
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This randomized controlled trial aims to investigate the effects of Mobilization With Movement (MWM) combined with exercise therapy on tendon morphology, pain, and functional outcomes in individuals with rotator cuff tendinopathy. A total of approximately 60 participants diagnosed with supraspinatus tendinopathy will be randomly assigned to either an exercise-only group or an exercise plus MWM group. All participants will undergo a standardized rehabilitation program for 8 weeks. Clinical outcomes, including pain intensity (Visual Analog Scale), shoulder function (SPADI and QuickDASH), range of motion, muscle strength, proprioception, and psychosocial status (Tampa Scale of Kinesiophobia, Pain Catastrophizing Scale, and Central Sensitization Inventory), will be assessed at baseline and post-intervention. In addition, ultrasound imaging will be used to evaluate tendon morphology, including tendon thickness, subacromial bursa thickness, acromiohumeral distance, echogenicity, and vascularity. The primary objective is to determine whether MWM produces superior improvements in clinical outcomes and whether it is associated with measurable changes in tendon structure as assessed by ultrasound. The findings are expected to contribute to a better understanding of the biomechanical and neurophysiological mechanisms underlying manual therapy in rotator cuff tendinopathy and to provide evidence for its role in musculoskeletal rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedStudy Start
First participant enrolled
July 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 13, 2026
June 18, 2026
June 1, 2026
5 months
June 15, 2026
June 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Supraspinatus Tendon Thickness
Supraspinatus tendon thickness will be measured using musculoskeletal ultrasound imaging. Measurements will be obtained at the tendon footprint in the longitudinal plane using a high-frequency linear transducer. Tendon thickness will be recorded in millimeters (mm). This variable is selected as the primary structural outcome to evaluate morphological changes associated with the intervention. Increased or decreased tendon thickness will be interpreted in relation to clinical improvement and tissue remodeling.
Baseline (Week 0) and post-intervention (Week 8)
Secondary Outcomes (9)
Pain Intensity
Baseline (Week 0) and post-intervention (Week 8)
Shoulder Pain and Disability Index (SPADI)
Baseline (Week 0) and post-intervention (Week 8)
QuickDASH Score
Baseline (Week 0) and post-intervention (Week 8)
Shoulder Range of Motion (ROM)
Baseline (Week 0) and post-intervention (Week 8)
Shoulder Muscle Strength
Baseline (Week 0) and post-intervention (Week 8)
- +4 more secondary outcomes
Study Arms (2)
Exercise Only Group
ACTIVE COMPARATORParticipants will receive a standardized shoulder exercise program focusing on rotator cuff strengthening, scapular stabilization, stretching, and range of motion exercises.
Exercise + Mobilization With Movement (MWM) Group
EXPERIMENTALParticipants will receive the same standardized exercise program in addition to glenohumeral joint Mobilization With Movement (MWM) techniques.
Interventions
A standardized physiotherapy program including rotator cuff strengthening exercises, scapular stabilization exercises, posterior capsule stretching, pectoralis minor stretching, and active range of motion exercises for the shoulder.3 sessions per week for 8 weeks (supervised and/or home-based depending on protocol design)
Glenohumeral joint Mobilization With Movement techniques (Mulligan concept), including posterior glide and inferior glide techniques applied during active shoulder movement, aimed at improving pain-free range of motion and function. Application Details: Grade: Sustained glide during active movement Techniques: Posterior glide, inferior glide Dosage: 2 sessions per week for 8 weeks Performed by licensed physiotherapist
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Clinical diagnosis of rotator cuff tendinopathy (supraspinatus involvement) confirmed by musculoskeletal ultrasound
- Shoulder pain duration of at least 3 months
- Pain intensity ≥ 3/10 on the Visual Analog Scale (VAS)
- Ability to understand and follow instructions and complete questionnaires
You may not qualify if:
- Full-thickness or large rotator cuff tear confirmed by ultrasound or MRI
- History of shoulder surgery on the affected side
- Diagnosis of adhesive capsulitis (frozen shoulder)
- Shoulder instability or dislocation history
- Cervical radiculopathy or referred neck-related shoulder pain
- Inflammatory rheumatic diseases (e.g., rheumatoid arthritis, ankylosing spondylitis)
- Neurological disorders affecting upper extremity function
- Corticosteroid injection in the shoulder within the last 6 months
- Ongoing physiotherapy or manual therapy treatment for shoulder pain in the last 3 months
- Severe systemic or psychiatric conditions that may interfere with participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ömer ÖZÇELEP, Assist. Prof.
Kirsehir Ahi Evran Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the interventions, participants and care providers cannot be blinded to group allocation. However, outcome assessments will be performed by an independent assessor who is blinded to group assignment. The assessor will not be involved in the treatment process or randomization procedures. This single-blind design is used to minimize assessment bias in both clinical and ultrasound-based outcome measures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 18, 2026
Study Start
July 8, 2026
Primary Completion (Estimated)
December 12, 2026
Study Completion (Estimated)
December 13, 2026
Last Updated
June 18, 2026
Record last verified: 2026-06